First City Capital Management, Inc. Novartis Ag Transaction History

First City Capital Management, Inc.

$186 Million
Q4 2024

A detailed history of First City Capital Management, Inc. transactions in Novartis Ag stock. As of the latest transaction made, First City Capital Management, Inc. holds 4,626 shares of NVS stock, worth $462,461. This represents 0.24% of its overall portfolio holdings.

Number of Shares

4,626

Previous 5,361 13.71%

Holding current value

$462,461

Previous $616,000 26.95%

% of portfolio

0.24%

Previous 0.32%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 03, 2025	SELL	$96.78 - $117.18 $71,133 - $86,127	-735 Reduced 13.71%	4,626 $450,000
Q3 2024 Nov 07, 2024	BUY	$106.13 - $120.89 $2,653 - $3,022	25 Added 0.47%	5,361 $616,000
Q2 2024 Aug 13, 2024	BUY	$92.57 - $107.37 $92 - $107	1 Added 0.02%	5,336 $568,000
Q1 2024 May 22, 2024	SELL	$95.27 - $108.47 $5,906 - $6,725	-62 Reduced 1.15%	5,335 $516,000
Q4 2023 Feb 07, 2024	SELL	$92.27 - $101.54 $14,855 - $16,347	-161 Reduced 2.9%	5,397 $544,000
Q2 2023 Jul 19, 2023	SELL	$92.52 - $104.91 $18,504 - $20,982	-200 Reduced 3.47%	5,558 $560,000
Q1 2023 May 01, 2023	BUY	$80.03 - $92.81 $20,007 - $23,202	250 Added 4.54%	5,758 $529,000
Q4 2022 Feb 13, 2023	SELL	$75.55 - $92.52 $18,887 - $23,130	-250 Reduced 4.34%	5,508 $499,000
Q3 2022 Oct 24, 2022	SELL	$74.61 - $87.26 $2,238 - $2,617	-30 Reduced 0.52%	5,758 $438,000
Q1 2022 May 04, 2022	BUY	$80.11 - $90.62 $12,096 - $13,683	151 Added 2.68%	5,788 $508,000
Q4 2021 Feb 07, 2022	SELL	$79.7 - $88.13 $93,647 - $103,552	-1,175 Reduced 17.25%	5,637 $486,000
Q2 2021 Aug 13, 2021	BUY	$85.24 - $94.15 $60,094 - $66,375	705 Added 11.54%	6,812 $633,000
Q1 2021 May 13, 2021	SELL	$83.5 - $98.47 $835 - $984	-10 Reduced 0.16%	6,107 $535,000
Q4 2020 Feb 12, 2021	SELL	$78.07 - $94.43 $315,871 - $382,063	-4,046 Reduced 39.81%	6,117 $564,000
Q3 2020 Nov 16, 2020	BUY	$82.14 - $91.0 $369,712 - $409,591	4,501 Added 79.49%	10,163 $883,000
Q2 2020 Aug 14, 2020	BUY	$80.93 - $91.1 $20,313 - $22,866	251 Added 4.64%	5,662 $494,000
Q1 2020 May 15, 2020	SELL	$70.67 - $99.01 $3,533 - $4,950	-50 Reduced 0.92%	5,411 $446,000
Q4 2019 Feb 10, 2020	BUY	$84.35 - $95.37 $10,037 - $11,349	119 Added 2.23%	5,461 $517,000
Q3 2019 Nov 13, 2019	SELL	$85.54 - $94.26 $5,046 - $5,561	-59 Reduced 1.09%	5,342 $464,000
Q1 2019 May 13, 2019	SELL	$75.32 - $86.15 $75,320 - $86,150	-1,000 Reduced 15.62%	5,401 $519,000
Q4 2018 Feb 13, 2019	SELL	$73.66 - $82.02 $7,734 - $8,612	-105 Reduced 1.61%	6,401 $549,000
Q2 2017 Aug 14, 2017	BUY	N/A	6,506	6,506 $543,000

Others Institutions Holding NVS

# of Institutions

1,423

Shares Held

130M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $215B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First City Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First City Capital Management, Inc. with notifications on news.

Account

First City Capital Management, Inc. Novartis Ag Transaction History